Nature Communications,
Journal Year:
2019,
Volume and Issue:
10(1)
Published: Aug. 2, 2019
Abstract
Hypomethylating
agents
decitabine
and
azacytidine
are
regarded
as
interchangeable
in
the
treatment
of
acute
myeloid
leukemia
(AML).
However,
their
mechanisms
action
remain
incompletely
understood,
predictive
biomarkers
for
HMA
efficacy
lacking.
Here,
we
show
that
bioactive
metabolite
triphosphate,
but
not
functions
activator
substrate
triphosphohydrolase
SAMHD1
is
subject
to
SAMHD1-mediated
inactivation.
Retrospective
immunohistochemical
analysis
bone
marrow
specimens
from
AML
patients
at
diagnosis
revealed
expression
leukemic
cells
inversely
correlates
with
clinical
response
decitabine,
azacytidine.
ablation
increases
antileukemic
activity
cell
lines,
primary
blasts,
xenograft
models.
acquire
resistance
partly
by
up-regulation.
Together,
our
data
suggest
a
biomarker
stratified
use
hypomethylating
potential
target
decitabine-resistant
leukemia.
Chemical Reviews,
Journal Year:
2016,
Volume and Issue:
116(23), P. 14379 - 14455
Published: Nov. 23, 2016
Nucleoside,
nucleotide,
and
base
analogs
have
been
in
the
clinic
for
decades
to
treat
both
viral
pathogens
neoplasms.
More
than
20%
of
patients
on
anticancer
chemotherapy
treated
with
one
or
more
these
analogs.
This
review
focuses
chemical
synthesis
biology
nucleoside,
that
are
FDA-approved
clinical
development
since
2000.
We
highlight
cellular
analogs,
drug
resistance
mechanisms,
compound
specificity
towards
different
cancer
types.
Furthermore,
we
explore
analog
syntheses
as
well
improved
scale-up
syntheses.
conclude
a
discussion
what
might
lie
ahead
medicinal
chemists,
biologists,
physicians
they
try
improve
efficacy
through
prodrug
strategies
combinations.
Cell Reports,
Journal Year:
2017,
Volume and Issue:
20(8), P. 1921 - 1935
Published: Aug. 1, 2017
Highlights•SAMHD1
deficiency
or
Vpx-mediated
degradation
sensitizes
cells
to
DSB-inducing
agents•SAMHD1
localizes
DNA
double-strand
breaks
in
response
damage•SAMHD1
promotes
HR
and
end
resection
independent
of
its
dNTPase
activity•SAMHD1
complexes
with
CtIP
facilitates
recruitment
damage
sitesSummaryDNA
break
(DSB)
repair
by
homologous
recombination
(HR)
is
initiated
CtIP/MRN-mediated
maintain
genome
integrity.
SAMHD1
a
dNTP
triphosphohydrolase,
which
restricts
HIV-1
infection,
mutations
are
associated
Aicardi-Goutières
syndrome
cancer.
We
show
that
has
dNTPase-independent
function
promoting
facilitate
DSB
HR.
causes
hypersensitivity
agents,
recruited
DSBs.
via
conserved
C-terminal
domain
recruits
DSBs
Significantly,
cancer-associated
mutant
impaired
interaction,
but
not
dNTPase-inactive
SAMHD1,
fails
rescue
the
impairment
depletion.
Our
findings
define
for
HR-mediated
facilitating
accrual
promote
resection,
providing
insight
into
how
integrity.Graphical
abstract
Nature Communications,
Journal Year:
2025,
Volume and Issue:
16(1)
Published: Jan. 17, 2025
SAMHD1
is
a
dNTPase
that
impedes
replication
of
HIV-1
in
myeloid
cells
and
resting
T
lymphocytes.
Here
we
elucidate
the
substrate
activation
mechanism
SAMHD1,
which
involves
dNTP
binding
at
allosteric
sites
transient
tetramerization.
Our
findings
reveal
tetramerization
alone
insufficient
to
promote
hydrolysis;
instead,
requires
an
inactive
tetrameric
intermediate
with
partially
occupied
sites.
The
equilibrium
between
active
states
regulates
activity,
driven
by
dissociation
additional
ligands
preassembled
tetramer.
Furthermore,
catalytic
efficiency,
but
not
specificity,
modulated
identity
dNTPs
occupying
We
show
how
this
regulation
shapes
deoxynucleotide
homeostasis
balancing
production
SAMHD1-catalyzed
depletion.
Notably,
exhibits
distinct
functionality,
term
facilitated
depletion,
whereby
increased
biosynthesis
certain
enhances
depletion
others.
regulatory
relationship
different
sheds
light
on
emerging
role
biology
implications
for
HIV/AIDS,
innate
antiviral
immunity,
cell
disorders,
telomere
maintenance
therapeutic
efficacy
nucleoside
analogs.
Proceedings of the National Academy of Sciences,
Journal Year:
2014,
Volume and Issue:
111(41)
Published: Sept. 29, 2014
Significance
SAMHD1
is
a
dNTPase
that
depletes
the
cellular
dNTP
pool
to
inhibit
replication
of
retroviruses,
including
HIV-1.
The
activity
also
enables
enzyme
be
major
regulator
levels
in
mammalian
cells,
addition
implicated
pathogenesis
chronic
lymphocytic
leukemia
(CLL)
and
Aicardi
Goutières
syndrome
(AGS).
Here
we
present
extensive
structural
enzymatic
data
reveal
how
activated
regulated
via
combined
actions
GTP
all
dNTPs.
Our
work
establishes
complete
spectrum
nucleotide
binding
exquisite
regulatory
mechanism
metabolism,
retrovirus
restriction,
CLL
AGS.
Nucleic Acids Research,
Journal Year:
2015,
Volume and Issue:
43(13), P. 6486 - 6499
Published: June 22, 2015
The
HIV-1
restriction
factor
SAMHD1
is
a
tetrameric
enzyme
activated
by
guanine
nucleotides
with
dNTP
triphosphate
hydrolase
activity
(dNTPase).
In
addition
to
this
established
activity,
there
have
been
series
of
conflicting
reports
as
whether
the
also
possesses
single-stranded
DNA
and/or
RNA
3′-5′
exonuclease
activity.
was
purified
using
three
chromatography
steps,
over
which
DNase
largely
separated
from
dNTPase
but
RNase
persisted.
Surprisingly,
we
found
that
catalytic
and
nucleotide
activator
site
mutants
no
retained
activities.
Thus,
cannot
be
associated
any
known
binding
site.
Monomeric
bind
preferentially
RNA,
while
form
required
for
action
bound
weakly.
ssRNA
binding,
not
ssDNA,
induces
higher-order
oligomeric
states
are
distinct
binds
dNTPs.
We
conclude
trace
activities
detected
in
preparations
arise
persistent
contaminants
co-purify
HD
active
An
vivo
model
suggested
where
alternates
between
mutually
exclusive
functions
hydrolysis
depending
on
pool
levels
presence
viral
ssRNA.
Molecular Cancer,
Journal Year:
2015,
Volume and Issue:
14(1)
Published: Sept. 29, 2015
Regulation
of
intracellular
deoxynucleoside
triphosphate
(dNTP)
pool
is
critical
to
genomic
stability
and
cancer
development.
Imbalanced
dNTP
pools
can
lead
enhanced
mutagenesis
cell
proliferation
resulting
in
Therapeutic
agents
that
target
synthesis
metabolism
are
commonly
used
treatment
several
types
cancer.
Despite
studies,
the
molecular
mechanisms
regulate
levels
maintain
their
homeostasis
not
completely
understood.
The
discovery
SAMHD1
as
first
mammalian
triphosphohydrolase
provided
new
insight
into
regulation.
maintains
homeostatic
DNA
replication
damage
repair.
Recent
progress
indicates
gene
mutations
epigenetic
downregulation
activity
or
expression
multiple
cancers.
Impaired
function
cause
increased
instability
cell-cycle
progression,
thereby
facilitating
proliferation.
This
review
summarizes
latest
advances
understanding
importance
development
novel
regulating
this
process.
Proceedings of the National Academy of Sciences,
Journal Year:
2018,
Volume and Issue:
115(16)
Published: April 2, 2018
Sterile
alpha
motif
and
HD-domain-containing
protein
1
(SAMHD1)
blocks
replication
of
retroviruses
certain
DNA
viruses
by
reducing
the
intracellular
dNTP
pool.
SAMHD1
has
been
suggested
to
down-regulate
IFN
inflammatory
responses
viral
infections,
although
functions
mechanisms
in
modulating
innate
immunity
remain
unclear.
Here,
we
show
that
suppresses
immune
infections
stimuli
inhibiting
nuclear
factor-κB
(NF-κB)
activation
type
I
interferon
(IFN-I)
induction.
Compared
with
control
cells,
infection
SAMHD1-silenced
human
monocytic
cells
or
primary
macrophages
Sendai
virus
(SeV)
HIV-1,
treatment
stimuli,
induces
significantly
higher
levels
NF-κB
IFN-I
Exogenous
expression
reconstitution
knockout
induction
SeV
stimuli.
Mechanistically,
inhibits
interacting
NF-κB1/2
phosphorylation
inhibitory
IκBα.
also
interacts
inhibitor-κB
kinase
ε
(IKKε)
regulatory
factor
7
(IRF7),
leading
suppression
pathway
IKKε-mediated
IRF7
phosphorylation.
Interactions
endogenous
proteins
were
validated
macrophages.
Comparing
splenocytes
from
heterozygous
mice,
further
confirmed
SAMHD1-mediated
activation,
suggesting
an
evolutionarily
conserved
property
SAMHD1.
Our
findings
reveal
down-regulating
highlighting
importance
antiviral
immunity.
PLoS Pathogens,
Journal Year:
2015,
Volume and Issue:
11(10), P. e1005194 - e1005194
Published: Oct. 2, 2015
SAMHD1
restricts
HIV-1
infection
of
myeloid-lineage
and
resting
CD4+
T-cells.
Most
likely
this
occurs
through
deoxynucleoside
triphosphate
triphosphohydrolase
activity
that
reduces
cellular
dNTP
to
a
level
where
reverse
transcriptase
cannot
function,
although
alternative
mechanisms
have
been
proposed
recently.
Here,
we
present
combined
structural
virological
data
demonstrating
in
addition
allosteric
activation
activity,
restriction
correlates
with
the
capacity
form
"long-lived"
enzymatically
competent
tetramers.
Tetramer
disruption
invariably
abolishes
but
has
varied
effects
on
vitro
activity.
phosphorylation
also
ablates
tetramer
formation
without
affecting
steady-state
kinetics.
However
phospho-SAMHD1
is
unable
catalyse
turnover
under
conditions
nucleotide
depletion.
Based
our
findings
propose
model
for
phosphorylation-dependent
regulation
dephosphorylation
switches
housekeeping
found
cycling
cells
high-activity
stable
tetrameric
depletes
maintains
low
levels
dNTPs
differentiated
cells.